Epcoritamab in B-cell malignancies: current status and prospects

.

Source: Expert Opinion on Biological Therapy - February 12, 2024 Category: Drugs & Pharmacology Authors: Stefano MolicaMarco RossiDavid Allsupa Queens Centre for Oncology and Haematology, Castle Hill Hospital, Hull University NHS Trust, Hull, UKb Department Haematology, Azienda Ospedaliera-Universitaria “Renato Dulbecco”, Catanzaro, Italyc Università Ma Source Type: research